Epidiolex Published: June 14, 2022 Courtney Rhoads Twitter Facebook LinkedIn E-mail Comment Drug approved by the United States Food and Drug Administration in 2018 for the treatment of severe and rare forms of epilepsy, which contains cannabidiol. Share Twitter Facebook LinkedIn E-mail Comment Courtney Rhoads Read more posts [email protected] Your Name(Required) First Last Your Email(Required) Message(Required) Δ
